What insurance companies look for: Common prior authorization criteria include documented BMI meeting the FDA-approved threshold, documentation of weight-related comorbidities (for patients with BMI 27 to 29.9), evidence of previous weight loss attempts (diet, exercise, behavioral modification), a letter of medical necessity from your provider, and sometimes documentation that you have tried and failed other weight loss medications first (step therapy)
This product isn't available in your region
Through JIFSANs Cooperative Agreement with the U.S
Short-term trial: If you're testing GLP-1 medications for a brief period at a starting dose, Mochi Health's lower-tier medication pricing ($175/mo + $49 fee = $224/mo) is still more expensive than Losing Weight RX but may feel manageable for a short commitment
Whether you are purchasing a single vial or wholesale peptide kits, our commitment to consistency, transparency, and customer satisfaction remains the same
Other NASH-related biomarkers were decreased, and adiponectin was increased in patients with T2DM [62]
